Alexis A. Borisy's most recent trade in Revolution Medicines Inc was a trade of 11,574 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 26, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 11,574 | 11,574 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 3,142 | 2,338,884 (3%) | 0% | 0 | Common Stock | |
Blueprint Medicines Corp | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 128.12 per share. | 18 Jun 2025 | 3,902 | 78,062 (0%) | 0% | 128.1 | 499,924 | Common Stock |
Relay Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 136,681 | 136,681 | - | - | Stock Option (Right to Buy) | |
Tango Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
Tango Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 6,250 | 17,500 | - | 0 | Common Stock | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,955 | 15,955 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 2,336,294 (3%) | 0% | 0 | Common Stock | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,248 | 2,335,742 (3%) | 0% | 0 | Common Stock | |
Blueprint Medicines Corp | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 4,570 | 4,570 | - | - | Stock Option (Right to Buy) | |
Blueprint Medicines Corp | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,242 | 74,160 (0%) | 0% | 0 | Common Stock | |
Tango Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
Tango Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 6,250 | 11,250 | - | 0 | Common Stock | |
Relay Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | |
Opko Health Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Blueprint Medicines Corp | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 5,300 | 5,300 | - | - | Stock Option (Right to Buy) | |
Blueprint Medicines Corp | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 2,600 | 71,918 (0%) | 0% | 0 | Common Stock | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,200 | 239,822 (0%) | 0% | 0 | Common Stock | |
Tango Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Tango Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
Relay Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 66,055 | 66,055 | - | - | Stock Option (Right to Buy) | |
EQRx Inc | Alexis A. Borisy | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 15,148 | 2,892,491 | - | - | Earn-out Shares | |
Opko Health Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Blueprint Medicines Corp | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 2,600 | 69,318 (0%) | 0% | 0 | Common Stock | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 5,200 | 54,918 (0%) | 0% | 0 | Common Stock | |
Tango Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Relay Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 41,597 | 41,597 | - | - | Stock Option (Right to Buy) | |
Opko Health Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 312,612 | 312,612 (0%) | 0% | 0 | Common Stock | |
Opko Health Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
EQRx Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 18,810,000 | 18,810,000 | - | - | Common Stock | |
EQRx Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 2,877,343 | 2,877,343 | - | - | Earn-out Shares | |
EQRx Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 2,194,499 | 2,194,499 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 12,659 | 12,659 | - | - | Stock Option (Right to Buy) | |
Revolution Medicines Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 3,617 | 49,718 (0%) | 0% | 0 | Common Stock | |
Blueprint Medicines Corp | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,500 | 4,500 | - | - | Stock Option (Right to Buy) | |
Blueprint Medicines Corp | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,250 | 66,718 (0%) | 0% | 0 | Common Stock | |
Relay Therapeutics Inc | Alexis A. Borisy | Director | Other type of transaction at price $ 0.00 per share. | 11 Mar 2021 | 28,538 | 234,175 | - | 0 | Common Stock | |
Relay Therapeutics Inc | Alexis A. Borisy | Director | Other type of transaction at price $ 0.00 per share. | 19 Feb 2021 | 30,194 | 205,637 | - | 0 | Common Stock | |
Relay Therapeutics Inc | Alexis A. Borisy | Director | Other type of transaction at price $ 0.00 per share. | 05 Feb 2021 | 70,956 | 175,443 | - | 0 | Common Stock |